LCG
OFIX icon

Lisanti Capital Growth’s Orthofix Medical OFIX Stock Holding History

Lisanti Capital Growth’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-51,043
Closed -$2.21M – 151
2021
Q1 		$2.21M Buy
+51,043
New +$2.25M 0.28% 109
2016
Q3 		– Sell
-21,830
Closed -$926K – 105
2016
Q2 		$926K Buy
21,830
+12,060
+123% +$524K 1.4% 25
2016
Q1 		$406K Buy
+9,770
New +$383K 0.48% 88

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Lisanti Capital Growth's OFIX Position: Q2 2021 in Review

Lisanti Capital Growth sold out of Orthofix Medical (OFIX) in Q2 2021, closing a stake of 51,043 shares — an estimated $2.21M sold.

Lisanti Capital Growth first reported a position in OFIX in Q1 2016 and held it in 3 quarters. The position peaked at $2.21M in Q1 2021. 134 funds tracked by Wall St. Rank hold OFIX as of Q2 2021.

  • Lisanti Capital Growth reported no remaining Orthofix Medical position as of Q2 2021 after selling out during the quarter.
  • Lisanti Capital Growth sold 51,043 Orthofix Medical shares in Q2 2021, an estimated $2.21M.
  • Lisanti Capital Growth first reported a position in Orthofix Medical in Q1 2016 and held it in 3 quarters.
  • Lisanti Capital Growth's Orthofix Medical position peaked at $2.21M in Q1 2021.
  • 134 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2021.

Based on Lisanti Capital Growth's 13F filing for Q2 2021, filed 16 Aug 2021.